首页> 外文期刊>Expert opinion on drug safety >Disturbance of vision by COX-2 inhibitors.
【24h】

Disturbance of vision by COX-2 inhibitors.

机译:COX-2抑制剂对视力的干扰。

获取原文
获取原文并翻译 | 示例
           

摘要

In this review, 35 cases of acute, reversible, sometimes severe, disturbances of vision closely associated with the use of celecoxib or rofecoxib are described. These were identified from three different databases using strict selection criteria. The events included temporary blindness, visual field defect, scotoma, teichopsia, blurred vision, decreased vision and abnormal vision. The reactions had a mean onset time of 9.5 days and recovery occurred within 3 days following withdrawal of the drug. The reactions do not appear to be related to age, gender, dose, or indication for use. The incidence of reported cases is estimated to be not less than 5 per 10,000 patients. Possible mechanisms for this type of reaction are described. The most likely appears to be the result of interference with the retinal blood supply through reduced production of prostanoids. Genetic polymorphisms that affect drug metabolism or uptake could be risk factors and are discussed along with suggestions for research.
机译:在这篇综述中,描述了35例与塞来昔布或罗非考昔的使用密切相关的急性,可逆,有时甚至是严重的视力障碍。这些都是使用严格的选择标准从三个不同的数据库中识别出来的。这些事件包括暂时性失明,视野缺损,葡萄球菌,手足口病,视力模糊,视力下降和视力异常。反应的平均发作时间为9.5天,停药后3天内恢复。这些反应似乎与年龄,性别,剂量或使用指示无关。据报告,该病例的发病率不低于每10,000名患者5例。描述了这种反应的可能机理。最可能的原因似乎是通过减少前列腺素的产生而干扰视网膜血液供应的结果。影响药物代谢或吸收的遗传多态性可能是危险因素,并将与研究建议一起讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号